Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 631 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Recruiting

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

NCT07673016

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +21 more
Locations
  • Urology San Diego Oceanside, California, United States
  • Genesis Research, LLC San Diego, California, United States
  • Urology Associates of Silicon Valley San Jose, California, United States
  • UroPartners, LLC Chicago, Illinois, United States
View all 23 locations
View Trial Details
Recruiting

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

NCT07480356

Conditions
Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Carcinoma in Situ, +16 more
Locations
  • East Valley Urology Center of Arizona Queen Creek, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Michael Oefelein Clinical Trials Bakersfield, California, United States
  • Renown Regional Medical Center St Louis, Missouri, United States
View Trial Details
Recruiting

Integrated Cancer Repository for Cancer Research

NCT02012699

Conditions
Abdominal Neoplasms, Adenoma, Adenomatous Polyposis Coli, +195 more
Locations
  • Advent Health Greenwood Village, Colorado, United States
  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital Manchester, Connecticut, United States
  • Florida Hospital Memorial Medical Center Daytona Beach, Florida, United States
  • Florida Hospital DeLand DeLand, Florida, United States
View all 42 locations
View Trial Details
Recruiting

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

NCT07225127

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +15 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details
Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

NCT07327489

Conditions
Advanced Solid Tumors Cancer, Bladder Cancer, Breast Diseases, +64 more
Locations
  • Mercy Hospital - FTS Fort Smith, Arkansas, United States
  • Frederick Health Hospital Frederick, Maryland, United States
  • Mercy Hospital - SPG Springfield, Missouri, United States
  • Mercy Hospital - South St Louis, Missouri, United States
View Trial Details
Recruiting

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

NCT07232602

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • UCSF Medical Center at Mission Bay ( Site 5044) San Francisco, California, United States
  • University of Chicago Medical Center ( Site 5037) Chicago, Illinois, United States
  • Cleveland Clinic Taussig Cancer ( Site 5036) Cleveland, Ohio, United States
  • Huntsman Cancer Institute ( Site 5041) Salt Lake City, Utah, United States
View all 16 locations
View Trial Details
Recruiting

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

NCT05312671

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Johns Hopkins University: Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Recruiting

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

NCT06500455

Conditions
Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, +52 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 270 locations
View Trial Details

Related conditions